In order to improve the prognostic efficiency for postoperative HCC recurrence, we assessed the combination of AFP and CA19-9 as a single prognostic indicator, as sensitivity and specificity in tumor diagnosis can be significantly increased by combining two or more serum tumor markers [15, 16]. This evidence concerns the gene AFP and hepatocellular carcinoma.